Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Neuroblastoma, body mass index, and survival: a retrospective analysis.

Small AG, Thwe le M, Byrne JA, Lau L, Chan A, Craig ME, Cowell CT, Garnett SP.

Medicine (Baltimore). 2015 Apr;94(14):e713. doi: 10.1097/MD.0000000000000713.

PMID:
25860217
2.

A Review of Heterogeneous Photocatalysis for Water and Surface Disinfection.

Byrne JA, Dunlop PS, Hamilton JW, Fernández-Ibáñez P, Polo-López I, Sharma PK, Vennard AS.

Molecules. 2015 Mar 30;20(4):5574-5615. Review.

3.

Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.

Awe JP, Gschweng EH, Vega-Crespo A, Voutila J, Williamson MH, Truong B, Kohn DB, Kasahara N, Byrne JA.

Stem Cells Transl Med. 2015 Feb;4(2):136-45. doi: 10.5966/sctm.2014-0117. Epub 2015 Jan 9.

PMID:
25575527
4.
5.

Overexpressed oncogenic tumor-self antigens.

Bright RK, Bright JD, Byrne JA.

Hum Vaccin Immunother. 2014;10(11):3297-305. doi: 10.4161/hv.29475.

PMID:
25483660
6.

Developing neural stem cell-based treatments for neurodegenerative diseases.

Byrne JA.

Stem Cell Res Ther. 2014 May 30;5(3):72. doi: 10.1186/scrt461.

PMID:
25157920
7.

Informal urban green-space: comparison of quantity and characteristics in Brisbane, Australia and Sapporo, Japan.

Rupprecht CD, Byrne JA.

PLoS One. 2014 Jun 18;9(6):e99784. doi: 10.1371/journal.pone.0099784. eCollection 2014.

8.

Investigation of the inhibitory effects of TiO(2) on the β-amyloid peptide aggregation.

Ahmed MH, Byrne JA, Keyes TE.

Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:227-34. doi: 10.1016/j.msec.2014.03.011. Epub 2014 Mar 12.

PMID:
24863220
9.

Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Byrne JA, Frost S, Chen Y, Bright RK.

Tumour Biol. 2014 Aug;35(8):7369-82. doi: 10.1007/s13277-014-2006-x. Epub 2014 May 6. Review.

PMID:
24798974
10.

Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Shahheydari H, Frost S, Smith BJ, Groblewski GE, Chen Y, Byrne JA.

Mol Biol Rep. 2014 Jul;41(7):4565-72. doi: 10.1007/s11033-014-3327-y. Epub 2014 Mar 7.

11.

Color me healthy: food diversity in school community gardens in two rapidly urbanising Australian cities.

Guitart DA, Pickering CM, Byrne JA.

Health Place. 2014 Mar;26:110-7. doi: 10.1016/j.healthplace.2013.12.014. Epub 2013 Dec 31.

PMID:
24434081
12.

Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting.

Biesemann C, Grønborg M, Luquet E, Wichert SP, Bernard V, Bungers SR, Cooper B, Varoqueaux F, Li L, Byrne JA, Urlaub H, Jahn O, Brose N, Herzog E.

EMBO J. 2014 Jan 13;33(2):157-70. doi: 10.1002/embj.201386120. Epub 2014 Jan 10.

13.

Germline stem cells: toward the regeneration of spermatogenesis.

Valli H, Phillips BT, Shetty G, Byrne JA, Clark AT, Meistrich ML, Orwig KE.

Fertil Steril. 2014 Jan;101(1):3-13. doi: 10.1016/j.fertnstert.2013.10.052. Epub 2013 Dec 5. Review.

14.

Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.

Bright JD, Schultz HN, Byrne JA, Bright RK.

Oncoimmunology. 2013 Jul 1;2(7):e25049. Epub 2013 May 21.

15.

Tumor protein D52 represents a negative regulator of ATM protein levels.

Chen Y, Kamili A, Hardy JR, Groblewski GE, Khanna KK, Byrne JA.

Cell Cycle. 2013 Sep 15;12(18):3083-97. doi: 10.4161/cc.26146. Epub 2013 Aug 21.

16.

The association between TNF-α and insulin resistance in euglycemic women.

Walsh JM, McGowan CA, Byrne JA, Rath A, McAuliffe FM.

Cytokine. 2013 Oct;64(1):208-12. doi: 10.1016/j.cyto.2013.07.001. Epub 2013 Aug 14.

PMID:
23953853
17.

Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.

Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS.

Mol Genet Metab. 2013 Nov;110(3):222-30. doi: 10.1016/j.ymgme.2013.06.020. Epub 2013 Jul 6.

18.

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.

Awe JP, Lee PC, Ramathal C, Vega-Crespo A, Durruthy-Durruthy J, Cooper A, Karumbayaram S, Lowry WE, Clark AT, Zack JA, Sebastiano V, Kohn DB, Pyle AD, Martin MG, Lipshutz GS, Phelps PE, Pera RA, Byrne JA.

Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.

19.

Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells.

Messenger SW, Thomas DD, Falkowski MA, Byrne JA, Gorelick FS, Groblewski GE.

Am J Physiol Gastrointest Liver Physiol. 2013 Sep 15;305(6):G439-52. doi: 10.1152/ajpgi.00143.2013. Epub 2013 Jul 18.

20.

TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.

Roslan N, Bièche I, Bright RK, Lidereau R, Chen Y, Byrne JA.

Mol Carcinog. 2014 Oct;53(10):807-19. doi: 10.1002/mc.22038. Epub 2013 May 9.

PMID:
23661506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk